The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malaria
Abstract
In this study we explore the antimalarial effects of 3-hydroxypyridin-4-ones (CP compounds), a family of bidentate orally effective iron chelators in experimental animal systems in vivo and in vitro, and examine whether the iron chelator deferoxamine (DF) is active against human infection with P. falciparum. There was direct relation between lipid solubility of the CP compounds, which would facilitate membrane transit, and their in vivo antimalarial action, suggesting direct intracellular iron chelation as the most likely explantation for the antimalarial effect of iron chelators. Results of the double-blind, placebo controlled trial of DF in humans with asymptomatic parasitemia provided unequivocal evidence that this iron-chelating agent has antimalarial activity. Depriving the parasite of a metabolically important source of iron may represent a novel approach to antimalarial drug development. DF is a relatively ineffective intraerythrocytic chelator, and our data indicate that other orally effective iron chelators may have superior antimalarial activity in vivo. A systematic screening of available iron chelating drugs may result in the identification of potentially useful antimalarial compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the malarial parasite Plasmodium falciparum requires considerable iron for growth, and there is evidence that lowering the amount of available iron provides a promising route to antimalarials (e.g. [1478-1494]”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1480]
Citations
Cites
Jensen, J. B., & Trager, W. F. (1977) · PubMed · Cited by 356
Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation
Lederman, H., Cohen, A., Lee, J., Freedman, M., & Gelfand, E. (1984) · Blood · doi:10.1182/blood.v64.3.748.748 · Cited by 282
Jensen, J. B. (1978) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1978.27.1274 · Cited by 278
Jensen, J. B., & Trager, W. (1977) · The Journal of Parasitology · doi:10.2307/3279900 · Cited by 276
Effect of Iron Deficiency and Desferrioxamine on DNA Synthesis in Human Cells
Hoffbrand, A. V., Ganeshaguru, K., Hooton, J. W. L., & Tattersall, M. H. N. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03570.x · Cited by 241
1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, AN ORALLY ACTIVE CHELATOR FOR TREATMENT OF IRON OVERLOAD
Kontoghiorghes, G., Sheppard, L., Aldouri, M., & Hoffbrand, A. V. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90545-9 · Cited by 177
Porter, J. B., Gyparaki, M., Burke, L., Huehns, E. R., Sarpong, P., Saez, V., & Hider, R. C. (1988) · Blood · doi:10.1182/blood.v72.5.1497.1497 · Cited by 154
Self-citationPlasmodium Falciparum: Inhibition of in Vitro Growth by Desferrioxamine
Raventós-Suárez, C., Pollack, S., & Nagel, R. L. (1982) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1982.31.919 · Cited by 153
International Committee for Standardization in Hematology
(1971) · British Journal of Haematology · doi:10.1111/j.1365-2141.1971.tb07057.x · Cited by 151
Malaria — Resurgence, Resistance, and Research
Wyler, D. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198304143081505 · Cited by 148
Research works printed but not linked: 6
- Fritch, 1985, Exper. Path., 60, 171
- Gordeuk, 1992, Blood
- Torrance, 1968, South. Afr. J. Med. Sci., 33, 9
- Cabantchik, 1989, Blood, 74, 1464, 10.1182/blood.V74.5.1464.1464 · doi:10.1182/blood.v74.5.1464.1464
- Siddiqui, 1972, Proc. Helm. Soc., 39, 204
- Clarke, 1990, Clin. Research, 38, 300A
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Iron and immunity: a double-edged sword.
Weiss, G. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1070.x · Cited by 317
Design of iron chelators with therapeutic application
Liu, Z. D., & Hider, R. C. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00050-4 · Cited by 287
Self-citationDesign of clinically useful iron(III)‐selective chelators
Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266
Self-citation
Metadata
- Authors
- Hershko, C., Gordeuk, V. R., Brittenham, G. M., Thuma, P. E., Theanacho, E. N., Spira, D. T., Hider, R. C., & Peto, T. E. A.
- Affiliations
- Shaare Zedek Medical Center (IL)
- MetroHealth Medical Center (US)
- Pennsylvania State University (US)
- Hebrew University of Jerusalem (IL)
- King's College London (GB)
- University of Oxford (GB)
- Corresponding author
- Hershko, C.
- Venue
- Journal of Inorganic Biochemistry
- Publisher
- Elsevier BV
- Published
- 1992-08
- Volume
- 47
- Issue
- 1
- Pages
- 267-277
- ISSN
- 0162-0134 (ISSN-L)
- OpenAlex
- W2005699306
- Cited by
- 57
- References
- 28
- Citations by year
- 2022: 1 · 2021: 3 · 2019: 1 · 2017: 1 · 2016: 3 · 2014: 2 · 2013: 3 · 2012: 2
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Inorganic Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl042814-05)
- U.S. Food and Drug Administration (FD-R-000657-01)
- National Heart, Lung, and Blood Institute (R01 HL 42814)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- iron chelators, antimalarial activity, falciparum malaria, Plasmodium falciparum, deferoxamine, 3-hydroxypyridin-4-ones, lipid solubility, membrane permeability, asymptomatic parasitemia, antimalarial drug development
- MeSH terms
- Animals, Antimalarials, Disease Models, Animal, Female, Humans, Iron Chelating Agents, Malaria, Pyridones, Malaria, Falciparum, Rats, Wistar, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malaria. https://app.cochat.ai/papers/10.1016/0162-0134(92)84072-u
- The paper
- Hershko, C., Gordeuk, V. R., Brittenham, G. M., Thuma, P. E., Theanacho, E. N., Spira, D. T., Hider, R. C., & Peto, T. E. A. (1992). The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malaria. Journal of Inorganic Biochemistry. https://doi.org/10.1016/0162-0134(92)84072-u
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.